Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amantadine versus modafinil for fatigue in multiple sclerosis
IRCT20210511051267N1Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of amantadine and modafinil in multiple sclerosis (MS) (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Fatigue rate based on FSS questionnaire. Started Jul 2021; status: completed.
02
Drugs
amantadinemodafinil
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on IRCT20210511051267N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210511051267N1.